Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography
- 25 June 1998
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 712 (1-2) , 129-143
- https://doi.org/10.1016/s0378-4347(98)00165-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Altered Pharmacokinetics of Vinblastine in Mdr1a P-glycoprotein-Deficient MiceJNCI Journal of the National Cancer Institute, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Anthracycline and anthraquinone anticancer agents: Current status and recent developmentsPharmacology & Therapeutics, 1993
- Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1992
- HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patientsJournal of Pharmaceutical and Biomedical Analysis, 1991
- Comparative metabolism and pharmacokinetics of doxorubicin and 4′-epidoxorubicin in plasma, heart and tumor of tumor-bearing miceCancer Chemotherapy and Pharmacology, 1990
- Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing Ridgway Osteogenic Sarcoma (ROS)European Journal of Cancer and Clinical Oncology, 1986
- A fluorometric assay for daunomycin and adriamycin in animal tissuesBiochemical Medicine, 1973
- Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesiusBiotechnology & Bioengineering, 1969